Next Article in Journal
Functionability of NMDA-Receptors in an in vitro model of the Blood-Brain-Barrier
Previous Article in Journal
Antimicrobial and Antimutagenic Properties of Newly Synthesized Derivatives of Indolizine
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Abstract

Synthesis of a Building Block for Oligopeptide-Oligonucleotide Conjugates

Department of Medicinal Chemistry, University of Vienna, Althanstraße 14, 1090, Vienna, Austria
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2009, 77(7), 217; https://doi.org/10.3797/scipharm.oephg.21.PO-18
Submission received: 16 April 2009 / Accepted: 16 April 2009 / Published: 16 April 2009

Abstract

Antisense and siRNA oligonucleotides have been widely used in the past decade as an efficient gene-silencing tool in molecular biological investigations. However, their therapeutic application has hitherto been hampered by their poor pharmacokinetic properties.

Share and Cite

MDPI and ACS Style

DIRIN, M.; WINKLER, J.; URBAN, E.; NOE, C.R. Synthesis of a Building Block for Oligopeptide-Oligonucleotide Conjugates. Sci. Pharm. 2009, 77, 217. https://doi.org/10.3797/scipharm.oephg.21.PO-18

AMA Style

DIRIN M, WINKLER J, URBAN E, NOE CR. Synthesis of a Building Block for Oligopeptide-Oligonucleotide Conjugates. Scientia Pharmaceutica. 2009; 77(Posters (PO)):217. https://doi.org/10.3797/scipharm.oephg.21.PO-18

Chicago/Turabian Style

DIRIN, M., J. WINKLER, E. URBAN, and C. R. NOE. 2009. "Synthesis of a Building Block for Oligopeptide-Oligonucleotide Conjugates" Scientia Pharmaceutica 77, Posters (PO): 217. https://doi.org/10.3797/scipharm.oephg.21.PO-18

Article Metrics

Back to TopTop